A detailed history of Neuberger Berman Group LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Neuberger Berman Group LLC holds 248,468 shares of EXAS stock, worth $10.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
248,468
Holding current value
$10.5 Million
% of portfolio
0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$56.27 - $73.77 $14 Million - $18.3 Million
248,468 New
248,468 $17.2 Million
Q4 2023

Feb 09, 2024

BUY
$59.06 - $75.72 $43,468 - $55,729
736 Added 5.18%
14,951 $1.11 Million
Q3 2023

Nov 14, 2023

SELL
$65.94 - $99.04 $39,695 - $59,622
-602 Reduced 4.06%
14,215 $969,000
Q2 2023

Aug 11, 2023

SELL
$62.68 - $95.05 $86,749 - $131,549
-1,384 Reduced 8.54%
14,817 $1.39 Million
Q1 2023

May 12, 2023

BUY
$47.19 - $70.77 $21,848 - $32,766
463 Added 2.94%
16,201 $1.1 Million
Q4 2022

Feb 13, 2023

SELL
$30.35 - $53.15 $129,351 - $226,525
-4,262 Reduced 21.31%
15,738 $779,000
Q3 2022

Nov 15, 2022

SELL
$31.97 - $49.37 $179,159 - $276,669
-5,604 Reduced 21.89%
20,000 $650,000
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $105,797 - $226,479
2,971 Added 13.13%
25,604 $1.01 Million
Q1 2022

May 13, 2022

SELL
$57.56 - $82.54 $32,521 - $46,635
-565 Reduced 2.44%
22,633 $1.58 Million
Q4 2021

Feb 11, 2022

SELL
$72.5 - $100.68 $24.1 Million - $33.4 Million
-331,898 Reduced 93.47%
23,198 $1.79 Million
Q3 2021

Nov 12, 2021

BUY
$90.24 - $124.05 $2.84 Million - $3.91 Million
31,507 Added 9.74%
355,096 $33.9 Million
Q2 2021

Aug 13, 2021

BUY
$93.66 - $139.27 $1.2 Million - $1.78 Million
12,779 Added 4.11%
323,589 $40.2 Million
Q1 2021

May 13, 2021

BUY
$116.57 - $155.01 $2.92 Million - $3.89 Million
25,089 Added 8.78%
310,810 $40.9 Million
Q4 2020

Feb 10, 2021

BUY
$99.61 - $142.12 $148,717 - $212,185
1,493 Added 0.53%
285,721 $37.9 Million
Q3 2020

Nov 12, 2020

BUY
$72.92 - $102.01 $1.82 Million - $2.54 Million
24,905 Added 9.6%
284,228 $29 Million
Q2 2020

Aug 13, 2020

SELL
$55.75 - $92.75 $234,540 - $390,199
-4,207 Reduced 1.6%
259,323 $22.5 Million
Q1 2020

May 14, 2020

SELL
$37.9 - $104.44 $999,536 - $2.75 Million
-26,373 Reduced 9.1%
263,530 $15.3 Million
Q4 2019

Feb 12, 2020

BUY
$77.66 - $99.74 $6.21 Million - $7.97 Million
79,941 Added 38.07%
289,903 $26.8 Million
Q3 2019

Nov 13, 2019

BUY
$90.37 - $122.49 $485,829 - $658,506
5,376 Added 2.63%
209,962 $19 Million
Q2 2019

Aug 13, 2019

BUY
$89.51 - $118.04 $427,857 - $564,231
4,780 Added 2.39%
204,586 $24.2 Million
Q1 2019

May 13, 2019

BUY
$61.98 - $96.5 $10.1 Million - $15.7 Million
162,855 Added 440.73%
199,806 $17.3 Million
Q4 2018

Feb 12, 2019

SELL
$56.04 - $82.66 $52,285 - $77,121
-933 Reduced 2.46%
36,951 $2.33 Million
Q3 2018

Nov 13, 2018

BUY
$48.29 - $80.6 $44,523 - $74,313
922 Added 2.49%
37,884 $2.99 Million
Q2 2018

Aug 13, 2018

BUY
$37.84 - $69.96 $787,601 - $1.46 Million
20,814 Added 128.9%
36,962 $2.21 Million
Q1 2018

May 08, 2018

BUY
$39.82 - $57.53 $643,013 - $928,994
16,148 New
16,148 $651,000
Q4 2017

Feb 14, 2018

SELL
$46.49 - $60.51 $12.4 Million - $16.1 Million
-266,433 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$37.05 - $47.12 $9.87 Million - $12.6 Million
266,433
266,433 $12.6 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.48B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.